The Orphan Device Problem: What Happens When MDR Compliance Exceeds Product Revenue The crisis is most acute for devices treating rare conditions or pediatric populations
External resources American Journal of Clinical Nutrition: Nutritional priorities to support GLP-1 therapy for obesity Endocrine Society: Protein may protect against muscle loss on semaglutide (ENDO 2025) Impact of semaglutide on body composition in adults with overweight or obesity: STEP 1 study For researchers serious about optimizing their peptide protocols and nutrition strategies during GLP-1 therapy, SeekPeptides offers the most comprehensive resource available, with evidence-based guides, proven protocols, personalized calculators, and a community of thousands who have navigated these exact questions
Peptide of the Month Meet AOD-9604 the fat-burning fragment thats been making waves
publish the founding characterization paper, "Ipamorelin, the first selective growth hormone secretagogue", in European Journal of Endocrinology
If approved, the doctor can electronically send the prescription to a pharmacy or arrange for home delivery if available
